• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为吲哚胺2,3-双加氧酶1(IDO1)抑制剂的咪唑并噻唑衍生物的晶体结构与构效关系

Crystal Structures and Structure-Activity Relationships of Imidazothiazole Derivatives as IDO1 Inhibitors.

作者信息

Tojo Shingo, Kohno Tetsuya, Tanaka Tomoyuki, Kamioka Seiji, Ota Yosuke, Ishii Takayuki, Kamimoto Keiko, Asano Shigehiro, Isobe Yoshiaki

机构信息

Dainippon Sumitomo Pharma Co., Ltd. , 3-1-98 Kasugade-naka, Konohana-ku, Osaka 554-0022, Japan.

出版信息

ACS Med Chem Lett. 2014 Aug 21;5(10):1119-23. doi: 10.1021/ml500247w. eCollection 2014 Oct 9.

DOI:10.1021/ml500247w
PMID:25313323
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4190630/
Abstract

Indoleamine 2,3-dioxygenase 1 (IDO1) is considered as a promising target for the treatment of several diseases, including neurological disorders and cancer. We report here the crystal structures of two IDO1/IDO1 inhibitor complexes, one of which shows that Amg-1 is directly bound to the heme iron of IDO1 with a clear induced fit. We also describe the identification and preliminary optimization of imidazothiazole derivatives as novel IDO1 inhibitors. Using our crystal structure information and structure-activity relationships (SAR) at the pocket-B of IDO1, we found a series of urea derivatives as potent IDO1 inhibitors and revealed that generation of an induced fit and the resulting interaction with Phe226 and Arg231 are essential for potent IDO1 inhibitory activity. The results of this study are very valuable for understanding the mechanism of IDO1 activation, which is very important for structure-based drug design (SBDD) to discover potent IDO1 inhibitors.

摘要

吲哚胺2,3-双加氧酶1(IDO1)被认为是治疗多种疾病的一个有前景的靶点,这些疾病包括神经紊乱和癌症。我们在此报告了两种IDO1/IDO1抑制剂复合物的晶体结构,其中一种显示Amg-1通过明显的诱导契合直接结合到IDO1的血红素铁上。我们还描述了咪唑并噻唑衍生物作为新型IDO1抑制剂的鉴定和初步优化。利用我们的晶体结构信息以及IDO1口袋-B处的构效关系(SAR),我们发现了一系列脲衍生物作为有效的IDO1抑制剂,并揭示诱导契合的产生以及由此与苯丙氨酸226和精氨酸231的相互作用对于有效的IDO1抑制活性至关重要。这项研究的结果对于理解IDO1激活机制非常有价值,这对于基于结构的药物设计(SBDD)以发现有效的IDO1抑制剂非常重要。

相似文献

1
Crystal Structures and Structure-Activity Relationships of Imidazothiazole Derivatives as IDO1 Inhibitors.作为吲哚胺2,3-双加氧酶1(IDO1)抑制剂的咪唑并噻唑衍生物的晶体结构与构效关系
ACS Med Chem Lett. 2014 Aug 21;5(10):1119-23. doi: 10.1021/ml500247w. eCollection 2014 Oct 9.
2
Important Hydrogen Bond Networks in Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Design Revealed by Crystal Structures of Imidazoleisoindole Derivatives with IDO1.吲哚胺 2,3-双加氧酶 1(IDO1)抑制剂设计中的重要氢键网络:与 IDO1 的咪唑异吲哚衍生物的晶体结构揭示
J Med Chem. 2016 Jan 14;59(1):282-93. doi: 10.1021/acs.jmedchem.5b01390. Epub 2015 Dec 21.
3
Discovery and preliminary structure-activity relationship of 1H-indazoles with promising indoleamine-2,3-dioxygenase 1 (IDO1) inhibition properties.具有良好吲哚胺-2,3-双加氧酶1(IDO1)抑制特性的1H-吲唑类化合物的发现及初步构效关系
Bioorg Med Chem. 2016 Dec 1;24(23):6194-6205. doi: 10.1016/j.bmc.2016.10.003. Epub 2016 Oct 6.
4
A Series of 2-((1-Phenyl-1H-imidazol-5-yl)methyl)-1H-indoles as Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.一系列 2-((1-苯基-1H-咪唑-5-基)甲基)-1H-吲哚作为吲哚胺 2,3-双加氧酶 1(IDO1)抑制剂。
ChemMedChem. 2021 Jul 20;16(14):2195-2205. doi: 10.1002/cmdc.202100107. Epub 2021 May 26.
5
Identification and preliminary structure-activity relationships of 1-Indanone derivatives as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors.新型吲哚胺-2,3-双加氧酶1(IDO1)抑制剂1-茚酮衍生物的鉴定及其初步构效关系
Bioorg Med Chem. 2017 Jul 15;25(14):3780-3791. doi: 10.1016/j.bmc.2017.05.017. Epub 2017 May 10.
6
Correlation of indoleamine-2,3-dioxigenase 1 inhibitory activity of 4,6-disubstituted indazole derivatives and their heme binding affinity.4,6-二取代吲唑衍生物的吲哚胺-2,3-双加氧酶1抑制活性与其血红素结合亲和力的相关性
Bioorg Med Chem Lett. 2019 Oct 1;29(19):126607. doi: 10.1016/j.bmcl.2019.08.011. Epub 2019 Aug 7.
7
Unique Sulfur-Aromatic Interactions Contribute to the Binding of Potent Imidazothiazole Indoleamine 2,3-Dioxygenase Inhibitors.独特的硫-芳环相互作用有助于强效咪唑并噻唑吲哚胺 2,3-双加氧酶抑制剂的结合。
J Med Chem. 2020 Feb 27;63(4):1642-1659. doi: 10.1021/acs.jmedchem.9b01549. Epub 2020 Feb 10.
8
Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening.通过高通量筛选发现并表征新型吲哚胺 2,3-双加氧酶 1 抑制剂的天然产物。
Acta Pharmacol Sin. 2020 Mar;41(3):423-431. doi: 10.1038/s41401-019-0246-4. Epub 2019 Jun 13.
9
High-resolution structures of inhibitor complexes of human indoleamine 2,3-dioxygenase 1 in a new crystal form.人吲哚胺2,3-双加氧酶1抑制剂复合物的新晶体形式的高分辨率结构
Acta Crystallogr F Struct Biol Commun. 2018 Nov 1;74(Pt 11):717-724. doi: 10.1107/S2053230X18012955. Epub 2018 Oct 17.
10
Discovery of Icotinib-1,2,3-Triazole Derivatives as IDO1 Inhibitors.1,2,3-三唑类埃克替尼衍生物作为吲哚胺2,3-双加氧酶1抑制剂的发现。
Front Pharmacol. 2020 Sep 30;11:579024. doi: 10.3389/fphar.2020.579024. eCollection 2020.

引用本文的文献

1
GAPDH heme delivery to Indoleamine 2,3-dioxygenase 1 involves their complex formation and complementary charge pairing at the protein-protein interface.甘油醛-3-磷酸脱氢酶向吲哚胺2,3-双加氧酶1传递血红素涉及它们在蛋白质-蛋白质界面处形成复合物以及互补电荷配对。
J Biol Chem. 2025 Jul 1;301(8):110443. doi: 10.1016/j.jbc.2025.110443.
2
Discovery of Novel Imidazothiazole-Based Hydroxamic Acid Derivatives as Potent Indoleamine 2,3-Dioxygenase 1 and Histone Deacetylase 6 Dual Inhibitors.发现新型基于咪唑并噻唑的异羟肟酸衍生物作为强效吲哚胺2,3-双加氧酶1和组蛋白去乙酰化酶6双重抑制剂
Molecules. 2025 Jun 7;30(12):2508. doi: 10.3390/molecules30122508.
3
Mechanochemical Approach for Metal-Free Regioselective C5-Sulfenylation of Imidazo[2,1-b]Thiazoles.咪唑并[2,1 - b]噻唑无金属区域选择性C5 - 亚磺酰化的机械化学方法
ChemSusChem. 2025 Aug 6;18(16):e202500320. doi: 10.1002/cssc.202500320. Epub 2025 May 12.
4
Transition Metal-Driven Selectivity in Direct C-H Arylation of Imidazo[2,1-b]Thiazole.咪唑并[2,1-b]噻唑直接C-H芳基化反应中过渡金属驱动的选择性
ChemistryOpen. 2024 Nov;13(11):e202400180. doi: 10.1002/open.202400180. Epub 2024 Jul 25.
5
Synthesis and Biological Evaluation of Novel 2-Amino-1,4-Naphthoquinone Amide-Oxime Derivatives as Potent IDO1/STAT3 Dual Inhibitors with Prospective Antitumor Effects.新型 2-氨基-1,4-萘醌酰胺肟衍生物的合成及生物评价作为潜在的抗肿瘤效应的 IDO1/STAT3 双重抑制剂。
Molecules. 2023 Aug 19;28(16):6135. doi: 10.3390/molecules28166135.
6
Carboranes in drug discovery, chemical biology and molecular imaging.碳硼烷在药物发现、化学生物学和分子成像中的应用。
Nat Rev Chem. 2022 Jul;6(7):486-504. doi: 10.1038/s41570-022-00400-x. Epub 2022 Jun 23.
7
Multicomponent Reaction-Assisted Drug Discovery: A Time- and Cost-Effective Green Approach Speeding Up Identification and Optimization of Anticancer Drugs.多组分反应辅助药物发现:一种省时、经济且绿色的方法,可加速抗癌药物的鉴定和优化。
Int J Mol Sci. 2023 Apr 1;24(7):6581. doi: 10.3390/ijms24076581.
8
Design, synthesis and biological evaluation of erlotinib-based IDO1 inhibitors.基于厄洛替尼的吲哚胺2,3-双加氧酶1(IDO1)抑制剂的设计、合成及生物学评价
Front Pharmacol. 2022 Aug 10;13:940704. doi: 10.3389/fphar.2022.940704. eCollection 2022.
9
Structure-based optimization of type III indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.基于结构的 III 型色氨酸 2,3-双加氧酶 1(IDO1)抑制剂的优化。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):1773-1811. doi: 10.1080/14756366.2022.2089665.
10
Novel 1,2,3-Triazole Erlotinib Derivatives as Potent IDO1 Inhibitors: Design, Drug-Target Interactions Prediction, Synthesis, Biological Evaluation, Molecular Docking and ADME Properties Studies.新型1,2,3-三唑厄洛替尼衍生物作为有效的吲哚胺2,3-双加氧酶1(IDO1)抑制剂:设计、药物-靶点相互作用预测、合成、生物学评价、分子对接及药物代谢动力学性质研究
Front Pharmacol. 2022 May 23;13:854965. doi: 10.3389/fphar.2022.854965. eCollection 2022.

本文引用的文献

1
Kynurenines in the CNS: recent advances and new questions.中枢神经系统中的犬尿氨酸:最新进展与新问题。
Nat Rev Drug Discov. 2013 Jan;12(1):64-82. doi: 10.1038/nrd3793. Epub 2012 Dec 14.
2
Rational design of 4-aryl-1,2,3-triazoles for indoleamine 2,3-dioxygenase 1 inhibition.4-芳基-1,2,3-三唑类化合物的理性设计及其对吲哚胺 2,3-双加氧酶 1 的抑制作用。
J Med Chem. 2012 Jun 14;55(11):5270-90. doi: 10.1021/jm300260v. Epub 2012 May 22.
3
Indoleamine 2,3-dioxygenase expression in human cancers: clinical and immunologic perspectives.色氨酸 2,3-双加氧酶在人类癌症中的表达:临床和免疫观点。
Clin Cancer Res. 2011 Nov 15;17(22):6985-91. doi: 10.1158/1078-0432.CCR-11-1331. Epub 2011 Nov 8.
4
Purification and kinetic characterization of human indoleamine 2,3-dioxygenases 1 and 2 (IDO1 and IDO2) and discovery of selective IDO1 inhibitors.人吲哚胺2,3-双加氧酶1和2(IDO1和IDO2)的纯化及动力学特性研究与选择性IDO1抑制剂的发现
Biochim Biophys Acta. 2011 Dec;1814(12):1947-54. doi: 10.1016/j.bbapap.2011.07.023. Epub 2011 Jul 31.
5
Structure and reaction mechanism in the heme dioxygenases.血红素加氧酶的结构与反应机制。
Biochemistry. 2011 Apr 12;50(14):2717-24. doi: 10.1021/bi101732n. Epub 2011 Mar 18.
6
Challenges and opportunities for new protein crystallization strategies in structure-based drug design.基于结构的药物设计中新蛋白质结晶策略的挑战与机遇。
Expert Opin Drug Discov. 2010 Nov;5(11):1039-45. doi: 10.1517/17460441.2010.515583.
7
Discovery of potent competitive inhibitors of indoleamine 2,3-dioxygenase with in vivo pharmacodynamic activity and efficacy in a mouse melanoma model.在小鼠黑色素瘤模型中发现具有体内药效学活性和疗效的吲哚胺2,3-双加氧酶强效竞争性抑制剂。
J Med Chem. 2009 Dec 10;52(23):7364-7. doi: 10.1021/jm900518f.
8
Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenase.基于结构的吲哚胺2,3-双加氧酶苯基咪唑衍生抑制剂的开发
J Med Chem. 2008 Aug 28;51(16):4968-77. doi: 10.1021/jm800512z. Epub 2008 Jul 30.
9
Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape.吲哚胺2,3-双加氧酶在T细胞耐受和肿瘤免疫逃逸中的作用
Immunol Rev. 2008 Apr;222:206-21. doi: 10.1111/j.1600-065X.2008.00610.x.
10
Indoleamine 2,3-dioxygenase and tumor-induced tolerance.吲哚胺2,3-双加氧酶与肿瘤诱导的免疫耐受。
J Clin Invest. 2007 May;117(5):1147-54. doi: 10.1172/JCI31178.